We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

$AKRO insiders have traded $AKRO stock on the open market 74 times in the past 6 months. Of those trades, 4 have been purchases and 70 have been sales.

"Today, we're not connected enough with nature," explains Olivier Cresp, a master perfumer and co-founder of the fragrance ...

American Century Companies Inc. lifted its holdings in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 55.1 ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best performing pharma stocks so far in 2025. On February 20, Jared Holz ...

Corebridge Financial Inc. lowered its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 7.0% in ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best performing healthcare stocks so far in 2025. Despite the ongoing craze ...

Jonathan Young, the Chief Operating Officer of $AKRO, sold 607 shares of the company on 03-12-2025 for an estimated $27,242. We received data on the trade from a ...

Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company’s lead product candidate is efruxifermin (EFX ...

NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...